12506176

Source:http://linkedlifedata.com/resource/pubmed/id/12506176

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0030705, umls-concept:C0086960, umls-concept:C0205390, umls-concept:C0205420, umls-concept:C0221910, umls-concept:C0278996, umls-concept:C1442989, umls-concept:C1519810, umls-concept:C1522449, umls-concept:C1554217, umls-concept:C1707455
pubmed:issue	1
pubmed:dateCreated	2002-12-30
pubmed:abstractText	The Head and Neck Intergroup conducted a phase III randomized trial to test the benefit of adding chemotherapy to radiation in patients with unresectable squamous cell head and neck cancer.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/CA04919, http://linkedlifedata.com/resource/pubmed/grant/CA04920, http://linkedlifedata.com/resource/pubmed/grant/CA16116, http://linkedlifedata.com/resource/pubmed/grant/CA21115, http://linkedlifedata.com/resource/pubmed/grant/CA23318, http://linkedlifedata.com/resource/pubmed/grant/CA58416, http://linkedlifedata.com/resource/pubmed/grant/CA66636, http://linkedlifedata.com/resource/pubmed/grant/CA73590, http://linkedlifedata.com/resource/pubmed/grant/VA14028
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/12506176-14551314
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	0732-183X
pubmed:author	pubmed-author:AdamsGeorge LGL, pubmed-author:AdelsteinDavid JDJ, pubmed-author:EnsleyJohn FJF, pubmed-author:ForastiereArlene AAA, pubmed-author:KishJulie AJA, pubmed-author:LiYiY, pubmed-author:SchullerDavid EDE, pubmed-author:WagnerHenryHJr
pubmed:issnType	Print
pubmed:day	1
pubmed:volume	21
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	92-8
pubmed:dateRevised	2007-11-14
pubmed:meshHeading	pubmed-meshheading:12506176-Adult, pubmed-meshheading:12506176-Aged, pubmed-meshheading:12506176-Aged, 80 and over, pubmed-meshheading:12506176-Antineoplastic Agents, pubmed-meshheading:12506176-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:12506176-Cisplatin, pubmed-meshheading:12506176-Combined Modality Therapy, pubmed-meshheading:12506176-Disease-Free Survival, pubmed-meshheading:12506176-Dose Fractionation, pubmed-meshheading:12506176-Female, pubmed-meshheading:12506176-Fluorouracil, pubmed-meshheading:12506176-Head and Neck Neoplasms, pubmed-meshheading:12506176-Humans, pubmed-meshheading:12506176-Male, pubmed-meshheading:12506176-Middle Aged, pubmed-meshheading:12506176-Neoplasms, Squamous Cell, pubmed-meshheading:12506176-Statistics, Nonparametric, pubmed-meshheading:12506176-Survival Rate, pubmed-meshheading:12506176-United States
pubmed:year	2003
pubmed:articleTitle	An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer.
pubmed:affiliation	Cleveland Clinic Foundation, Department of Hematology and Medical Oncology, Ohio 44195, USA. adelstd@ccf.org
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III